Login to Your Account



Pharma: Other News To Note


Monday, April 1, 2013
• Retina Institute Japan K.K. (RIJ), of Fukuoka, Japan, and Dainippon Sumitomo Pharma Co. Ltd. (DSP), of Osaka, Japan, signed an agreement under which DSP invests into RIJ to discuss an alliance that would put iPS cell technology for age-related macular degeneration to practical use.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription